News Category
Lantern Pharma's Phase 1a data for LP-184 in recurrent glioblastoma show tolerability and a recommended dose, supporting a planned Phase 1b/2a trial c...
MIT researchers have developed a method to engineer donor immune cells that nearly eliminated lymphoma in mice within three weeks without rejection, p...
GeoVax Labs will implement a 1-for-24 reverse stock split on November 11, 2026, to restore compliance with Nasdaq's $1.00 minimum bid price requiremen...
The American Heart Association is establishing the Center for the Brain to deepen understanding of the heart-brain connection and help people live lon...
The three-day virtual Sickle Cell Caregiver Summit, running November 13-15, 2026, brings caregivers, patients, and healthcare professionals together w...
A new health impact assessment shows that China's revised 25 µg m⁻³ annual PM2.5 standard could avert nearly four times as many premature deaths as th...
Prof. Nancy Ip of HKUST has received the 2026 UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences for her work on Alzheimer...
A new review identifies the EGFR signaling pathway as a central driver of mucus hypersecretion in asthma, COPD, cystic fibrosis, and respiratory infec...
Global pediatric stroke deaths and disability have fallen sharply since 1990, but a new analysis shows rising incidence among adolescents and persiste...
Kairos Pharma received the 2026 Biotech Breakthrough Award for its investigational therapy ENV-105, which targets drug resistance in metastatic prosta...
A mouse study suggests an aqueous extract of Phyllanthus urinaria L may shield renal tubules from cisplatin-induced acute kidney injury by easing infl...
Heidelberg Pharma will present new clinical data on its lead ATAC candidate, pamlectabart tismanitin (HDP-101), and its second candidate, HDP-102, at ...
A new expert consensus from the Chinese Medical Association provides 34 recommendations to standardize surgical management of unilateral Wilms tumor, ...
Sequencio Therapeutics, a CK Life Sciences subsidiary, will present preclinical data at SITC 2026 showing its TROP2 and PD-L1/PRAME cancer vaccines ge...
Kairos Pharma's ENV-105 demonstrated a statistically significant improvement in progression-free survival for metastatic castration-resistant prostate...
University of Virginia researchers have developed an experimental ultrasound-based technique to deliver therapeutic nanoparticles into the brain to fi...
A new expert consensus published in the World Journal of Pediatric Surgery provides 34 recommendations to standardize surgical management of unilatera...
A Mayo Clinic study has found that cerebrospinal fluid contains DNA from complex brain tumors, potentially enabling less invasive diagnosis and monito...
New preliminary research presented at the American Heart Association's Scientific Sessions 2026 links cannabis use to increased odds of cardiovascular...
New research reveals rural residents face nearly three times the risk of dying before hospital arrival after a heart attack, with Black adults and you...
A new analysis by SkinCure Oncology estimates that 4.7 million Americans are diagnosed with nonmelanoma skin cancer annually, sharply revising a decad...
VERAXA Biotech is expanding its use of human-relevant preclinical testing methods, including 3D tumor spheroid and patient-derived tumor models, to im...
A preclinical study of a dual-impact antibody that combats multiple tumor types in mice could widen the reach of immunotherapy, which has had profound...
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing value, including potential licensing, partnerships, ...
A Phase 3 trial shows that combining two immunotherapy drugs significantly extends survival in patients with a deadly form of lung cancer, offering ne...
VolitionRx has signed a nonbinding LOI with Missionpharma to develop and commercialize a lateral flow test for NETosis, initially targeting neonatal s...
The American Heart Association has expanded its free online Support Network to offer personalized peer connection and resources for heart disease and ...
Creative Biolabs is promoting three-dimensional tumor organoid co-culture services that let preclinical researchers study CAR-T and other immune cell ...
Creative Biolabs has launched an integrated OMV and exosome-boosted CAR-T development platform to help researchers overcome the major barriers that ha...
TransCode Therapeutics announced that its Phase 1a trial of TTX-MC138 met its primary safety endpoint with no dose-limiting toxicities and showed dise...
Oncotelic Therapeutics announced a peer-reviewed study showing its AI-powered PDAOAI platform identified a four-gene prognostic signature in hepatocel...
Coherence Neuro's $45 million Series A, co-led by Peter Thiel's Founders Fund and the OpenAI Startup Fund, will fund the first chronic human trial of ...
Researchers at Yale School of Medicine have discovered that recurrent brain cancers develop mutations that differ radically between subtypes, suggesti...
ECGI Holdings has hired IBN to expand investor awareness of its health care strategy, including its Avanta Group acquisition and plans for an AI-enabl...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies across its preclinical research programs to generate more clinically informative...
VERAXA Biotech is developing antibody-based cancer therapies that aim to improve treatment selectivity and reduce toxicity, with promising preclinical...
Bangladesh's massive measles outbreak, with over 200,000 suspected cases, serves as a warning to other nations as vaccination rates decline and outbre...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical programs, aiming to improve clinical relevance while cutting animal t...
Dr. Mona Mofid's ninth San Diego Top Doctor award, alongside patient-satisfaction and specialist honors, highlights how peer and patient validation ca...
Pentixapharm reports growing international evidence for Pentixafor PET in identifying unilateral primary aldosteronism, reinforcing the rationale for ...
A small German study found that a new therapeutic vaccine kept two-thirds of patients with aggressive brain tumors alive eight years after enrollment,...
TransCode Therapeutics will present updated Phase 1a clinical data for its lead candidate TTX-MC138, a therapy targeting miR-10b in advanced solid tum...
Creative BioTherapeutics has been nominated for the 2026 Prix Galien USA Best Startup award, highlighting its preclinical efforts to address cancer re...
A recent clinical trial of an experimental vaccine has extended survival in glioblastoma patients, signaling potential progress after more than 20 yea...
As GLP-1 weight-loss drugs like Ozempic and Wegovy gain popularity, facial volume loss—dubbed 'Ozempic face'—is driving interest in non-surgical rejuv...
New screening technologies are enabling earlier and more personalized breast cancer detection, which could significantly improve survival rates and bo...
VERAXA Biotech's BiTAC-ADC platform demonstrated significant tumor regression and a differentiated safety profile in preclinical studies, potentially ...
A UK study has identified a potential method to halt lung cancer in its early stages by eliminating 'immune fog,' but residual cancer in some mice sug...
